Effects of CPAP Therapy on Systemic Blood Pressure, Cardiac Rhythm and Catecholamines Concentration in Patients with Obstructive Sleep Apnea.
10.4046/trd.2000.49.6.715
- Author:
Ji Ho KANG
;
Sang Haak LEE
;
Young Mee CHOI
;
Soon Seog KWON
;
Young Kyoon KIM
;
Kwan Hyoung KIM
;
Jeong Sup SONG
;
Sung Hak PARK
;
Hwa Sik MOON
- Publication Type:Original Article
- Keywords:
Obstructive sleep apnea;
Cardiovascular dysfunction;
Hemodynamics;
Catecholamines;
Continuous positive airway pressure therapy
- MeSH:
Anoxia;
Arousal;
Arrhythmias, Cardiac;
Blood Pressure*;
Cardiovascular System;
Catecholamines*;
Heart Rate;
Hemodynamics;
Humans;
Incidence;
Norepinephrine;
Oxygen;
Plasma;
Polysomnography;
Sleep Apnea, Obstructive*;
Sympathetic Nervous System
- From:Tuberculosis and Respiratory Diseases
2000;49(6):715-723
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Obstructive sleep apnea syndrome (OSAS) affects systemic blood pressure and cardiac function. The development of cardiovascular dysfunction including the changes of systemic blood pressure and cardiac rhythm, suggests that recurrent hypoxia and arousals from sleep may increase a sympathetic nervous system activity. Continuous positive airway pressure(CPAP) therapy has been found to be an effective treatment of OSAS. However, only a few studies have investigated the cardiovascular and sympathetic effects of CPAP therapy. We evaluated influences of nasal CPAP therapy on the cardiovascular system and the sympathetic activity in patients with OSAS. METHODS: Thirteen patients with OSAS underwent CPAP therapy and were monitored using polysomnography, blood pressure, heart rate, presence of arrhythmia and the concentration of plasma catecholamines, before and with CPAP therapy. RESULTS: The apnea-hypopnea index (AHI) was significantly decreased (p<0.01) and the lowest arterial oxygen saturation level was elevated significantly after applying CPAP (p<0.01). Systolic blood pressure tended to decrease after CPAP but without statistical significance. Heart rates during sleep were not significantly different after CPAP. However, the frequency and number of types of arrhythmia decreased and sinus bradytachyarrhythmia disappeared after CPAP. Although there was no significantly decreased after CPAP (p<0.05). CONCLUSION: CPAP therapy decreased the apnea-hypopnea index, hypoxic episodes and plasma norepinephrine concentration. In addition, it decreased the incidence of arrhythmia and tended to decrease the systemic blood pressure. These results indicate that CPAP may play an important role in the prevention of cardiovascular complications in patients with OSAS.
